4//SEC Filing
Eleven Biotherapeutics, Inc. 4
Accession 0001485003-16-000174
$CARMCIK 0001485003operating
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 4:54 PM ET
Size
7.5 KB
Accession
0001485003-16-000174
Insider Transaction Report
Form 4
HURLY STEPHEN A
DirectorPresident and CEO
Transactions
- Award
Common Stock
2016-09-20+398,031→ 398,031 total - Award
Stock Option
2016-09-20+350,000→ 350,000 totalExercise: $3.37Exp: 2026-09-19→ Common Stock (350,000 underlying)
Footnotes (2)
- [F1]The reporting person acquired 398,031 shares of issuer common stock in exchange for a 9.9175% interest in Viventia Bio Inc. pursuant to the issuer's purchase of all of the outstanding capital stock of Viventia Bio Inc. on September 20, 2016. Of the 398,031 shares issued to the reporting person in the transaction, 39,803 shares are currently being held in escrow and are subject to forfeiture during the 15-month period following the transaction to satisfy claims arising as a result of Viventia Bio Inc.'s or the reporting person's breach of any of its or his representations, warranties or covenants in the share purchase agreement.
- [F2]25% of the shares subject to such option shall vest on the first anniversary of the date of grant of the option and an additional 6.25% of the shares underlying the option shall vest at the end of each successive three-month period thereafter until the fourth anniversary of the date of grant of the option.
Documents
Issuer
Eleven Biotherapeutics, Inc.
CIK 0001485003
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001485003
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 4:54 PM ET
- Size
- 7.5 KB